Medicare Enrolled
Dr. Jacques Ganem, MD
Optician · Charlotte, NC
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Ganem from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ganem?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Ganem
Dr. Jacques Ganem is an optician specialist in Charlotte, NC, with 20 years of NPI registration. Based on federal Medicare data, Dr. Ganem performed 2,706 Medicare services across 2,370 unique beneficiaries.
Between the years covered by Open Payments, Dr. Ganem received a total of $4,479 from 33 pharmaceutical and/or device companies across 190 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ganem is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 24% volume in NC
$4,479 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,706
Medicare services
Top 24% in NC for optician
2,370
Unique beneficiaries
$65
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~135 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Manual urinalysis with microscopic examination A urine test performed manually without automated equipment. The sample is examined under a microscope to check for abnormalities. |
607 | $4 | $17 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
309 | $84 | $158 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
259 | $8 | $10 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
237 | $7 | $45 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
229 | $62 | $110 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
221 | $171 | $585 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
131 | $116 | $263 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
71 | $129 | $231 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
60 | $19 | $264 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 54 | $130 | $786 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
53 | $105 | $295 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
49 | $170 | $626 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
48 | $72 | $185 |
| Abdominal X-ray, 1 view An X-ray image of the abdomen taken from a single angle to visualize internal structures. |
41 | $22 | $80 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
37 | $3 | $15 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
32 | $90 | $1,619 |
| Injection, garamycin, gentamicin, up to 80 mg | 32 | $2 | $7 |
| CT scan of abdomen and pelvis with contrast A CT scan of the abdomen and pelvis using contrast dye before and after administration to visualize internal structures. |
30 | $189 | $798 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
30 | $18 | $41 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
29 | $241 | $826 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
24 | $11 | $220 |
| CT scan of abdomen and pelvis, without contrast A computed tomography scan that creates detailed images of the abdominal and pelvic organs. The procedure is performed without the use of intravenous contrast dye. |
20 | $80 | $550 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
17 | $21 | $87 |
| Transurethral prostate removal with electrocautery This procedure involves removing the prostate gland through the urethra using an endoscope and an electrocautery knife to control bleeding. |
16 | $552 | $2,215 |
| Injection, tobramycin sulfate, up to 80 mg | 16 | $2 | $20 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
15 | $43 | $73 |
| Shock wave crushing of kidney stones A procedure that uses shock waves to break kidney stones into smaller pieces so they can pass more easily from the body. |
13 | $429 | $2,134 |
| Endoscopic removal of bladder or urethra growth, 2.0-5.0 cm This procedure uses an endoscope to destroy or remove a growth from the bladder or urethra that measures between 2.0 and 5.0 centimeters. |
13 | $211 | $1,332 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
13 | $307 | $1,850 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
2.7% high complexity
19.0% medium
78.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$4,479
Total received (2018-2024)
Avg $640/year across 7 years
Top 26% in NC for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
33
Companies
190
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,342 (96.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$137 (3.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$956
2023
$979
2022
$794
2021
$478
2020
$409
2019
$358
2018
$505
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Dendreon Pharmaceuticals LLC
$251
UROGEN PHARMA, INC.
$137
Myriad Genetic Laboratories, Inc.
$121
ABBVIE INC.
$109
Olympus America Inc.
$102
Astellas Pharma US Inc
$66
Blue Earth Diagnostics Limited
$42
BIOPROTECT MEDICAL, INC.
$40
PFIZER INC.
$36
PROCEPT BioRobotics Corporation
$23
Antares Pharma, Inc.
$15
Ambu Inc.
$14
Top 3 companies account for 53.2% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$890
Endo Pharmaceuticals Inc.
$420
ABBVIE INC.
$420
Dendreon Pharmaceuticals LLC
$377
Janssen Biotech, Inc.
$309
UROGEN PHARMA, INC.
$181
Boston Scientific Corporation
$180
Myovant Sciences Inc.
$147
Sumitomo Pharma America, Inc.
$147
PFIZER INC.
$147
AbbVie Inc.
$132
AbbVie, Inc.
$126
Retrophin, Inc.
$121
Myriad Genetic Laboratories, Inc.
$121
Laborie Medical Technologies Corp.
$119
Olympus America Inc.
$116
Blue Earth Diagnostics Limited
$107
NeoTract Inc.
$90
AngioDynamics, Inc.
$42
BIOPROTECT MEDICAL, INC.
$40
PROCEPT BioRobotics Corporation
$23
TOLMAR Pharmaceuticals, Inc.
$22
Merck Sharp & Dohme LLC
$22
Ferring Pharmaceuticals Inc.
$22
Clarus Therapeutics Inc.
$21
Sun Pharmaceutical Industries Inc.
$21
Smith+Nephew, Inc.
$20
Rochester Medical Corporation
$20
UroGen Pharma, Inc.
$19
Antares Pharma, Inc.
$15
Ambu Inc.
$14
Cook Medical LLC
$13
Coloplast Corp
$13
Top 3 companies account for 38.6% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · AQUABEAM SYSTEM · Androgel · Axumin · BIOPROTECT BALLOON IMPLANT SYSTEM · BOTOX · Cook · ELIGARD · ERLEADA · Erleada · FIRMAGON · GENERAL THERAPIES · JATENZO · JELMYTO · KEYTRUDA · LITHOVUE · LUPRON DEPOT · LithoVue · Lupron · Lupron Depot · MYRBETRIQ · NANOKNIFE · NanoKnife · ORGOVYX · Olympus Laser Devices · POSLUMA · PROLARIS · PROVENGE · STRAVIX · TITAN · UroLift · XIAFLEX · XTANDI · XYOSTED · Xtandi · YONSA · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Opticians within 10 mi
190
Per 100K population
16.8
County median income
$83,765
Nearest hospital
CAROLINAS MEDICAL CENTER/BEHAV HEALTH
1.8 mi
1.8 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Ganem is a clinical cardiology specialist, with above-average Medicare volume (top 24% in NC), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Ganem experienced with manual urinalysis with microscopic examination?
Based on Medicare claims data, Dr. Ganem performed 607 manual urinalysis with microscopic examination services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ganem receive payments from pharmaceutical companies?
Yes. Dr. Ganem received a total of $4,479 from 33 companies across 190 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ganem's costs compare to other opticians in Charlotte?
Dr. Ganem's average Medicare payment per service is $65. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ganem) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Charlotte
Browse opticians in Charlotte ranked by procedure volume and transparency data.
Highest volume
Top Opticians in NC
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in NC
Which NC opticians receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Endo Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Endo Pharmaceuticals Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology